[cs_content][cs_section parallax=”false” separator_top_type=”none” separator_top_height=”50px” separator_top_angle_point=”50″ separator_bottom_type=”none” separator_bottom_height=”50px” separator_bottom_angle_point=”50″ style=”margin: 0px;padding: 20px 0px;”][cs_row inner_container=”true” marginless_columns=”false” style=”margin: 0px auto;padding: 0px;”][cs_column fade=”false” fade_animation=”in” fade_animation_offset=”45px” fade_duration=”750″ type=”1/3″ style=”padding: 10px 0px 0px;”][x_image type=”none” src=”http://beatcc2018.wpengine.com/wp-content/uploads/2017/06/Agrawal-Anu-pediatric-hematology-oncology-ucsf-benioff-childrens-hospital-oakland.jpg” alt=”” link=”false” href=”#” title=”” target=”” info=”none” info_place=”top” info_trigger=”hover” info_content=””][x_image type=”none” src=”http://beatcc2018.wpengine.com/wp-content/uploads/2017/04/uscf-benioff.png” alt=”” link=”false” href=”#” title=”” target=”” info=”none” info_place=”top” info_trigger=”hover” info_content=””][x_line style=”border-top-width: 1px;”][/cs_column][cs_column fade=”false” fade_animation=”in” fade_animation_offset=”45px” fade_duration=”750″ type=”2/3″ style=”padding: 0px;”][cs_text class=”cs-ta-left”]
Dr. Anurag K. Agrawal
UCSF Benioff Children’s Hospital Oakland
[/cs_text][cs_text]Dr. Agrawal is a principal investigator in the early phase/novel therapeutics program at Children’s Hospital Oakland in addition to his clinical work in pediatric oncology and hematopoietic stem cell transplant. He is assistant director of the hematology/oncology fellowship program and additionally spends time on supportive care and international work.
Appointments: (510) 428-3372 to schedule.
747 52nd Street
Oakland, CA 94609
Phone: (510) 428-3539
E-mail: aagrawal@mail.cho.org[/cs_text][/cs_column][/cs_row][/cs_section][cs_section parallax=”false” separator_top_type=”none” separator_top_height=”50px” separator_top_angle_point=”50″ separator_bottom_type=”none” separator_bottom_height=”50px” separator_bottom_angle_point=”50″ style=”margin: 0px;padding: 0 0px 45px;”][cs_row inner_container=”true” marginless_columns=”false” style=”margin: 0px auto;padding: 0px;”][cs_column fade=”false” fade_animation=”in” fade_animation_offset=”45px” fade_duration=”750″ type=”1/1″ style=”padding: 0px;”][x_tab_nav type=”three-up” float=”top”][x_tab_nav_item title=”Background” active=”true”][x_tab_nav_item title=”Education” active=”true”][x_tab_nav_item title=”Selected Publications” active=”false”][/x_tab_nav][x_tabs][x_tab active=”true”]Dr. Agrawal is currently an Associate Hematologist/Oncologist at UCSF Benioff Children’s Hospital Oakland and a principal investigator in the Institution’s early phase/novel therapeutics program which was developed through grant funding from the St. Baldrick’s Foundation. He additionally serves as the director of the hematology/oncology inpatient/outpatient units and assistant director of the pediatric hematology/oncology fellowship program. Dr. Agrawal continues to maintain interest in international projects as well as supportive care.
Dr. Agrawal and his team are very excited to continue to offer opportunities for improved treatment for children with neuroblastoma and medulloblastoma through their collaboration with Dr. Giselle Sholler, Helen Devos Children’s Hospital, and the Beat Childhood Cancer (formerly NMTRC) consortium. [/x_tab][x_tab active=”true”]
August 2000 – May 2004 |
Baylor College of Medicine, Houston, Texas Doctor of Medicine |
June 2004 – June 2007 |
Children’s Hospital and Research Center Oakland, Oakland, CA Pediatric Residency |
July 2008 – June 2011 |
Children’s Hospital and Research Center Oakland, Oakland, CA Pediatric Hematology/Oncology Fellowship |
[/x_tab][x_tab active=”false”]Agrawal AK, Chang PP, Feusner J. Twice weekly Pneumocystis jiroveci prophylaxis with trimethoprim-sulfamethoxazole in pediatric patients with acute lymphoblastic leukemia. J Pediatr Hematol Oncol 2011;33:e1-e4.
Agrawal AK, Saini N, Gildengorin G, Feusner JH. Is routine computed tomographic scanning justified in the first week of persistent febrile neutropenia in children with malignancies? Pediatr Blood Cancer 2011;57:620-624.
Agrawal AK, Feusner JH. Management of tumour lysis syndrome in children: what is the evidence for rasburicase in non-hyperleucocytic leukaemia? Brit J Haematol 2011;153:275-277.
Agrawal AK, Hsu E, Neumyar L, Quirolo K, Flori HR. Red blood cell transfusion in pediatric patients with severe chronic anemia: how slow is necessary? Pediatr Blood Cancer 2012;58:466-468.
Hastings CH, Torkildson JC, Agrawal AK. Pediatric Hematology/Oncology Handbook. Children’s Hospital and Research Center Oakland, 2nd edition. Hoboken, NJ: Wiley Blackwell, 2012
Anglemyer A, Agrawal AK, Rutherford GW. Treatment of Kaposi sarcoma in children with HIV-1 infection. Cochrane Sys Database Rev 2014;1:CD009826.
Reddy-Holdcraft S, Mehta PS, Agrawal AK. Paclitaxel for relapsed or recurrent HIV-associated pediatric Kaposi sarcoma [correspondence]. AIDS 2014;28:800-802.
Agrawal AK, Hastings CA, Feusner J (eds). Supportive Care in Pediatric Oncology. Berlin: Springer, 2015
Agrawal AK, Feusner J. Supportive Care of Patients with Cancer. In: Lanzkowsky P, Lipton JM, Fish JD. Lanzkowsky Manual of Pediatric Hematology Oncology, 6th edition. London: Elsevier Science, 2016
Kesselheim JC, Agrawal AK, Bhatia N et al. Measuring pediatric hematology-oncology fellows’ skills in humanism and professionalism: a novel assessment instrument. Pediatric Blood Cancer DOI: 10.1002/pbc.26316
[/x_tab][/x_tabs][/cs_column][/cs_row][/cs_section][/cs_content]